Lanean...
Clinical outcome assessments in neuro-oncology: a regulatory perspective
Overall survival, progression-free survival, and to a lesser extent objective response rate, have long been the most widely accepted endpoints used to evaluate clinical benefit in oncology trials. More recently, clinical outcome assessments (COAs) that measure the impact of disease and treatment on...
Gorde:
| Argitaratua izan da: | Neurooncol Pract |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6760344/ https://ncbi.nlm.nih.gov/pubmed/31579517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npv062 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|